Results 51 to 60 of about 2,310 (209)
Objective: To describe the use of gastroprotection (GP) among new chronic users of NSAIDs in the Netherlands by gastrointestinal (GI) risk factor (RF) score. Methods: Data for this retrospective follow-up study were extracted from the PHARMO database. We
Gaugris, S +5 more
core +1 more source
The development of the gastric lesion is complex and the result of the imbalance between aggressive and protective factors, involving the generation of free radicals and disturbance in nitric oxide (NO) production.
José Gerardo Carneiro +9 more
doaj +1 more source
ABSTRACT The high prevalence of gastrointestinal (GI) diseases and their significant impact on the quality of life require new therapeutic strategies. The development of novel therapeutic strategies should prioritize targeting the fundamental pathophysiological mechanisms underlying these diseases, including inflammation, cellular proliferation, and ...
Sayedeh Azimeh Hosseini +7 more
wiley +1 more source
Gasztroenterológiai-reumatológiai konszenzus a hatékony gasztroprotekció szükségességéről nemszteroid gyulladáscsökkentők alkalmazásakor = Gastroenterologist-Rheumatologist Expert Consensus Addressing the Need of Effective Gastroprotection During Therapy with Non-Steroidal Anti-Inflammatory Drugs [PDF]
Non-steroidal anti-inflammatory drugs (NSAIDs) are essential agents in the treatment of musculoskeletal disorders. However, their use is associated with mucosal injury of gastrointestinal tract, including the development of peptic ulcer disease and its ...
Kovács, László +6 more
core +1 more source
We reviewed gastric ulcer healing by dopamine considering several distinctive duodenal key points. Selye and Szabo describe the cysteamine-induced duodenal ulcer in rats as a duodenal stress ulcer in patients.
Predrag Sikiric +24 more
doaj +1 more source
IntroductionUse of non-steroidal anti-inflammatory drugs (NSAIDs) has increased over the last few years and identification of gastrointestinal risk factors is a key factor for prevention of its complications.
Graça Coutinho +7 more
core +1 more source
Mohammed M Mehanna,1,2 Amina Tarek Mneimneh,2 Souraya Domiati,3 Ahmed N Allam4 1Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; 2Department of Pharmaceutical Technology, Faculty of Pharmacy, Beirut Arab ...
Mehanna MM +3 more
doaj
Possibilities of gastroprotective therapy in NSA1Dinduced gastropathies with De-Nol
Objective. To assess efficacy of De-Nol in NSAID-induced gastropathies. Material and Methods. 45 pts with rheumatic diseases taking NSAID with gastric and/or duodenal ulcer up to 1 cm of size or multiple (>10) gastric erosions (MGE) confirmed with ...
A. E. Karateev +2 more
doaj +1 more source
Histopathological analysis of gastric mucosa stained with HE and PAS of rats submitted to induction of ulcers with acetic acid. The animals were treated orally with vehicle (injured control), ranitidine, and SpHE (25 mg/kg) for 14 days. In A and B, observe preserved mucosa and submucosal layers (black asterisk) and presence of the barrier protection of
Cynthia Layse Ferreira de Almeida +9 more
wiley +1 more source
Traditional medicine and gastroprotective crude drugs
A frequent question when dealing with the search for gastroprotective compounds from natural sources is how far or close are both the plant preparations and extract amounts from the doses recommended in traditional medicine and what should be considered realistic levels for experimental studies. The administration way is oral and therefore extracts and
Schmeda-Hirschmann, G., Yesilada, E.
openaire +6 more sources

